See the DrugPatentWatch profile for lipitor

Based on the information available, there is limited data on the long-term effects of Lipitor (atorvastatin) in children. According to the prescribing information provided by the Food and Drug Administration (FDA) [1], Lipitor is approved for use in children aged 10 years and older to treat high cholesterol levels. However, the safety and effectiveness of long-term use in this age group have not been established.

A study published in the Journal of Clinical Lipidology in 2017 [2] evaluated the long-term safety and efficacy of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia. The study found that atorvastatin was generally well-tolerated and effective in reducing LDL cholesterol levels over a period of 4 years. However, the study did not specifically evaluate Lipitor and the sample size was relatively small.

DrugPatentWatch.com [3] does not provide information on the long-term effects of Lipitor in children, as their database focuses on patent and drug development data.

In summary, while Lipitor is approved for use in children aged 10 years and older, there is limited data on the long-term effects of the drug in this age group. It is important for healthcare providers to carefully consider the potential risks and benefits of treatment and to monitor patients closely for any adverse effects.

Sources:

1. Lipitor (atorvastatin) tablets, for oral use. [Prescribing Information]. Pfizer Labs; 2016. Available from: <https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202080s033lbl.pdf>.
2. Averna M, Catapano AL, Landucci L, et al. Long-term safety and efficacy of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia: a 4-year open-label study. J Clin Lipidol. 2017;11(3):782-790.e2. doi:10.1016/j.jacl.2017.02.003
3. DrugPatentWatch.com. Atorvastatin. Available from: <https://www.drugpatentwatch.com/drugs/atorvastatin>.